Cultural advice

The Australian National University acknowledges, celebrates and pays our respects to the Ngunnawal and Ngambri people of the Canberra region and to all First Nations Australians on whose traditional lands we meet and work, and whose cultures are among the oldest continuing cultures in human history.

Aboriginal and Torres Strait Islander peoples are advised that ANU Library collections may include images, names, voices, and other representations of deceased persons.

Material in the collection may contain terms, language or views that reflect the period in which the item was created and may be considered inappropriate today.

Prevention of hepatocellular carcinoma in nonviral-related liver diseases

dc.contributor.authorFan, Jian-Gao
dc.contributor.authorFarrell, Geoffrey
dc.date.accessioned2015-12-08T22:25:11Z
dc.date.issued2009
dc.date.updated2016-02-24T10:40:23Z
dc.description.abstractAlthough chronic infection with hepatitis B virus and/or hepatitis C virus are the most important risk factors for hepatocellular carcinoma (HCC) worldwide, other causes of cirrhosis can also lead to HCC. Given the high prevalence of alcoholism and the worldwide obesity epidemic, the relevant importance of nonviral liver disease-related HCC is expected to increase in the future. Some evidence supports mechanistic interactions between host or environmental factors and chronic viral hepatitis in the development of HCC. For example, food- and water-borne carcinogens have contributed to unusually high rates of HCC in parts of China and sub-Saharan Africa. With some of these conditions, appropriate public health measures to reduce the population's exposure to known etiologic agents, or early therapeutic intervention for 'at-risk' individuals before development of cirrhosis (e.g. hereditary hemochromatosis) can prevent HCC. Community-based programs to discourage and deal with excessive alcohol intake, to promote tobacco smoking awareness, to avoid exposure to aflatoxin and other food toxins, and measures to reduce the pandemic of obesity and diabetes are vital for effective interruption of the rising tide of HCC from nonviral liver disease.
dc.identifier.issn0815-9319
dc.identifier.urihttp://hdl.handle.net/1885/33332
dc.publisherBlackwell Publishing Ltd
dc.sourceJournal of Gastroenterology and Hepatology
dc.subjectKeywords: aflatoxin B1; alga toxin; antilipemic agent; antioxidant; chlorophyll; cocarcinogen; cryoprotective agent; estrogen; insulin sensitizing agent; mycotoxin; oltipraz; oral contraceptive agent; toxin; transferrin; unclassified drug; ursodeoxycholic acid; alc Aflatoxin; Alcoholism; Cirrhosis; Diabetes; Hereditary hemochromatosis; Non-alcoholic fatty liver disease; Obesity
dc.titlePrevention of hepatocellular carcinoma in nonviral-related liver diseases
dc.typeJournal article
local.bibliographicCitation.lastpage719
local.bibliographicCitation.startpage712
local.contributor.affiliationFan, Jian-Gao, Shanghai Jiaotong University
local.contributor.affiliationFarrell, Geoffrey, College of Medicine, Biology and Environment, ANU
local.contributor.authoruidFarrell, Geoffrey, u4028700
local.description.embargo2037-12-31
local.description.notesImported from ARIES
local.identifier.absfor110307 - Gastroenterology and Hepatology
local.identifier.ariespublicationu4201517xPUB101
local.identifier.citationvolume24
local.identifier.doi10.1111/j.1440-1746.2009.05776.x
local.identifier.scopusID2-s2.0-65949095045
local.identifier.thomsonID000266179800005
local.type.statusPublished Version

Downloads

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
01_Fan_Prevention_of_hepatocellular_2009.pdf
Size:
123.28 KB
Format:
Adobe Portable Document Format